Bio-Techne
TECH
#1488
Rank
A$18.58 B
Marketcap
$116.99
Share price
0.40%
Change (1 day)
2.11%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.95 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are A$0.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30A$1.00 B17.45%
2022-06-30A$0.85 B-6.9%
2021-06-30A$0.92 B-1.67%
2020-06-30A$0.93 B-8.37%
2019-06-30A$1.02 B47.4%
2018-06-30A$0.69 B-12.39%
2017-06-30A$0.79 B135.14%
2016-06-30A$0.33 B20.12%
2015-06-30A$0.28 B293.41%
2014-06-30A$71.33 M60.76%
2013-06-30A$44.37 M1.26%
2012-06-30A$43.82 M48.09%
2011-06-30A$29.59 M47.94%
2010-06-30A$20 M3.93%
2009-06-30A$19.24 M-9.06%
2008-06-30A$21.16 M4.22%
2007-06-30A$20.3 M-50.21%
2006-06-30A$40.78 M13.59%
2005-06-30A$35.9 M-11.56%
2004-06-30A$40.59 M1.69%
2003-06-30A$39.91 M-29.38%
2002-06-30A$56.52 M-23.6%
2001-06-30A$73.99 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$82.12 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.99 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.29 B 5,155.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$46.95 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.38 B 358.71%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$172.35 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.26 M-95.37%๐Ÿ‡บ๐Ÿ‡ธ USA